LabCompass

Christina Liscynesky

Medicine · The Ohio State University

Mid career · publishing since 2012

Publications

35

Citations

145

Est. group size

~2

Recurring co-author estimate

Active years

14

Publishing since 2012

Research summary
AI-generated

Christina Liscynesky's research focuses on infectious diseases in healthcare settings, including hospital-acquired infections like Clostridioides difficile, complications related to catheters used for IV access and dialysis, and infection risks for patients with weakened immune systems (such as those with low white blood cell counts from cancer treatment). Recent work also touches on molecular diagnostic testing for COVID-19 and treatment of sexually transmitted infections. This research is generally practical and clinical, aimed at improving infection prevention and treatment in hospitals.

Hospital-acquired infectionsClostridioides difficileCatheter-related complicationsInfection control and preventionMolecular diagnostics for infectious disease

Publication output has grown from a low base around 2017-2019 to a more consistent pace of several papers per year from 2020 onward, suggesting increasing activity over the past decade.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.4/year recently
2017: 2 publications17182019: 2 publications192020: 5 publications202021: 5 publications212022: 6 publications6222023: 3 publications232024: 6 publications6242025: 2 publications2526
Publishes in
  • Antimicrobial Stewardship & Healthcare Epidemiology×10
  • Biology of Blood and Marrow Transplantation×4
  • Open Forum Infectious Diseases×4
  • American Journal of Infection Control×3
  • Infection Control and Hospital Epidemiology×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile